Explore
13D/13G Activist Filings
119,213 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | ATRA | Atara Biotherapeutics, Inc. | Redmile Group, LLC | 13D/A | 9.9% | 751K |
| Nov 14, 2025 | TRML | TOURMALINE BIO, INC. | RA Capital Management, L.P. | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | SND | Smart Sand, Inc. | Tontine Asset Associates, LLC | 13G/A | 6.1% | 2.7M |
| Nov 14, 2025 | AMWL | American Well Corp | Caledonia (Private) Investments Pty Limited | 13G/A | 4.3% | 640K |
| Nov 14, 2025 | ALEC | Alector, Inc. | TCG Crossover GP II, LLC | 13G | 4.6% | 5.0M |
| Nov 14, 2025 | GSIW | Garden Stage Ltd | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | KDK | Ares Acquisition Corp II | Fort Baker Capital Management LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | SABS | SAB Biotherapeutics, Inc. | Woodline Partners LP | 13G | 9.9% | 7.1M |
| Nov 14, 2025 | COUR | Coursera, Inc. | Caledonia (Private) Investments Pty Limited | 13G | 5.6% | 9.3M |
| Nov 14, 2025 | TSHA | TAYSHA GENE THERAPIES, INC. | RA Capital Management, L.P. | 13G/A | 9.9% | 27.7M |
| Nov 14, 2025 | BDRX | Biodexa Pharmaceuticals Plc | Cavalry Fund I LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | VSH | VISHAY INTERTECHNOLOGY INC | Woodline Partners LP | 13G | 5.5% | 6.8M |
| Nov 14, 2025 | TECX | Tectonic Therapeutic, Inc. | EcoR1 Capital, LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | QSR | Restaurant Brands International Inc. | 3G Restaurant Brands Holdings General Partner Ltd. | 13D/A | 26.3% | 116.8M |
| Nov 14, 2025 | LNW | Light & Wonder, Inc. | Caledonia (Private) Investments Pty Limited | 13G/A | 9.6% | 7.8M |
| Nov 14, 2025 | EQ | Equillium, Inc. | Woodline Partners LP | 13G | 5.9% | 3.5M |
| Nov 14, 2025 | PTGX | Protagonist Therapeutics, Inc | BIOTECHNOLOGY VALUE FUND L P | 13G/A | 2.1% | 1.3M |
| Nov 14, 2025 | LDI | loanDepot, Inc. | PCP Managers GP, LLC | 13G/A | 46.3% | 103.5M |
| Nov 14, 2025 | LXEO | Lexeo Therapeutics, Inc. | Longitude Capital Partners IV, LLC | 13G/A | 3.8% | 2.8M |
| Nov 14, 2025 | UDMY | Udemy, Inc. | Caledonia (Private) Investments Pty Limited | 13G/A | 9.5% | 14.0M |
| Nov 14, 2025 | RXST | RxSight, Inc. | RA Capital Management, L.P. | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | PLRX | PLIANT THERAPEUTICS, INC. | Woodline Partners LP | 13G | 7.3% | 4.5M |
| Nov 14, 2025 | CMPX | Compass Therapeutics, Inc. | TANG CAPITAL MANAGEMENT, LLC | 13G/A | 10.0% | 17.2M |
| Nov 14, 2025 | ALXO | ALX Oncology Holdings Inc. | TANG CAPITAL MANAGEMENT, LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | SRTA | Strata Critical Medical, Inc. | Third Point LLC | 13G/A | 5.8% | 5.0M |
| Nov 14, 2025 | BOLT | Bolt Biotherapeutics, Inc. | TANG CAPITAL MANAGEMENT, LLC | 13G/A | 3.5% | 67K |
| Nov 14, 2025 | EPIX | ESSA Pharma Inc. | TANG CAPITAL MANAGEMENT, LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | NVRI | ENVIRI Corp | PARADIGM CAPITAL MANAGEMENT INC/NY | 13G/A | 4.7% | 3.8M |
| Nov 14, 2025 | COGT | Cogent Biosciences, Inc. | Point72 Asset Management, L.P. | 13G/A | 4.0% | 5.8M |
| Nov 14, 2025 | Z | Zillow Group, Inc. | Caledonia (Private) Investments Pty Limited | 13G/A | 23.4% | 11.6M |
| Nov 14, 2025 | FTW | EQV Ventures Acquisition Corp. | Fort Baker Capital Management LP | 13G/A | 10.0% | 3.6M |
| Nov 14, 2025 | AIRO | AIRO Group Holdings, Inc. | Woodline Partners LP | 13G/A | 8.5% | 2.8M |
| Nov 14, 2025 | VIRT | Virtu Financial, Inc. | Douglas A. Cifu | 13G/A | 4.7% | 4.1M |
| Nov 14, 2025 | PAX | Patria Investments Limited | Endure Capital Management, LLC | 13G/A | 6.6% | 4.3M |
| Nov 14, 2025 | VIK | Viking Holdings Ltd | Select Equity Group, L.P. | 13G/A | 4.9% | 15.3M |
| Nov 14, 2025 | HELP | CYBIN INC. | Point72 Asset Management, L.P. | 13G/A | 9.9% | 6.4M |
| Nov 14, 2025 | FWDI | Forward Industries, Inc. | C/M Capital Master Fund, LP | 13G/A | 0.4% | 339K |
| Nov 14, 2025 | MNPR | Monopar Therapeutics Inc. | RA Capital Management, L.P. | 13G/A | 9.9% | 743K |
| Nov 14, 2025 | EEIQ | EpicQuest Education Group International Ltd | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | N/A | NOBLE ROMANS INC | CORBEL CAPITAL PARTNERS SBIC, L.P. | 13G/A | 9.9% | 4.3M |
| Nov 14, 2025 | SGI | SOMNIGROUP INTERNATIONAL INC. | Select Equity Group, L.P. | 13G/A | 5.6% | 11.7M |
| Nov 14, 2025 | DNA | Ginkgo Bioworks Holdings, Inc. | Cascade Investment, L.L.C. | 13G/A | 7.5% | 3.6M |
| Nov 14, 2025 | SGMT | Sagimet Biosciences Inc. | Woodline Partners LP | 13G/A | 4.8% | 1.5M |
| Nov 14, 2025 | MIDD | MIDDLEBY CORP | Select Equity Group, L.P. | 13G/A | 8.3% | 4.2M |
| Nov 14, 2025 | SPKL | Spark I Acquisition Corp | First Trust Merger Arbitrage Fund | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | ZYME | Zymeworks Inc. | Redmile Group, LLC | 13G/A | 4.9% | 3.7M |
| Nov 14, 2025 | ALGS | Aligos Therapeutics, Inc. | Woodline Partners LP | 13G/A | 8.7% | 468K |
| Nov 14, 2025 | CFLT | Confluent, Inc. | Point72 Asset Management, L.P. | 13G/A | 6.0% | 17.5M |
| Nov 14, 2025 | VNME | Vendome Acquisition Corp I | Vendome Acquisition Sponsor I LLC | 13G/A | 20.0% | 5.0M |
| Nov 14, 2025 | CNM | Core & Main, Inc. | Select Equity Group, L.P. | 13G/A | 5.1% | 9.7M |